Actuate Therapeutics Files Proxy Materials
Ticker: ACTU · Form: DEFA14A · Filed: Apr 9, 2025 · CIK: 1652935
| Field | Detail |
|---|---|
| Company | Actuate Therapeutics, Inc. (ACTU) |
| Form Type | DEFA14A |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance
TL;DR
Actuate Therapeutics (formerly Apotheca) filed proxy docs. Shareholders vote soon.
AI Summary
Actuate Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on April 9, 2025. This filing relates to the company's solicitation of proxies for its upcoming shareholder meeting. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name on September 11, 2015.
Why It Matters
This filing is important for shareholders as it contains information and proposals that will be voted on at the company's shareholder meeting, impacting corporate governance and future decisions.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement and does not contain information about significant financial events or strategic shifts.
Key Players & Entities
- ACTUATE THERAPEUTICS, INC. (company) — Registrant
- Apotheca Therapeutics, Inc. (company) — Former company name
- 0001683168-25-002345 (filing_id) — Accession Number
- 20250409 (date) — Filing Date
FAQ
What is the purpose of this DEFA14A filing?
This filing is for Definitive Additional Materials related to the solicitation of proxies for Actuate Therapeutics, Inc.'s shareholder meeting.
When was Actuate Therapeutics, Inc. formerly known as?
Actuate Therapeutics, Inc. was formerly known as Apotheca Therapeutics, Inc.
When did the company change its name?
The company changed its name from Apotheca Therapeutics, Inc. on September 11, 2015.
What is the company's primary industry?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Where is Actuate Therapeutics, Inc. located?
The company's business and mailing address is 1751 River Run, Suite 400, Fort Worth, TX 76107.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 9, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).